관상동맥 스텐트 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Coronary Stents Market was valued at USD 6.7 billion in 2025 and is estimated to grow at a CAGR of 8.2% to reach USD 14.6 billion by 2035.

Market growth is driven by the rising prevalence of cardiovascular diseases, an aging population, advancements in stent technologies, and the increasing adoption of minimally invasive procedures. Coronary stents are tubular devices inserted into narrowed or blocked coronary arteries to maintain vessel patency, enhance blood flow, and prevent heart attacks. The growing incidence of coronary artery disease, a leading cause of mortality worldwide, is fueling demand. Technological innovations such as drug-eluting stents, bioresorbable scaffolds, and polymer-free stents improve long-term outcomes by minimizing restenosis and thrombosis. Rising patient awareness, clinician confidence, and the expansion of revascularization procedures further support adoption. Trends such as the shift toward drug-eluting and biodegradable stents, as well as patient-centric approaches, are shaping industry growth globally.

The drug-eluting stent segment held a share of 84.8% in 2025 owing to its ability to minimize restenosis, enhance long-term patient outcomes, and support minimally invasive interventions. Drug-eluting stents release medication to prevent excessive tissue growth, providing superior long-term results compared to bare-metal stents, which reinforces their widespread clinical adoption.

The cobalt-chromium alloy segment is expected to reach USD 7.5 billion by 2035. Cobalt-chromium stents offer high tensile strength and durability, maintaining vessel expansion under arterial pressure while allowing thinner strut designs. These thinner struts reduce arterial injury, improve blood flow, and accelerate healing, while minimizing the risk of restenosis and thrombosis, driving segment growth.

North America Coronary Stents Market held a 39.6% share in 2025. The U.S. faces a significant burden of cardiovascular diseases, driven by sedentary lifestyles, high-fat diets, and stress, which increases the demand for coronary stent procedures. The region's advanced healthcare infrastructure, specialized cardiac centers, and skilled medical professionals ensure widespread availability of stenting procedures. The adoption of innovative stent technologies across hospitals and interventional cardiology centers further fuels regional growth.

Prominent players in the Global Coronary Stents Market include Abbott, Medtronic, Boston Scientific, Biotronik, MicroPort Scientific, Stryker, Terumo, B. Braun, Biosensors International Group, Cook Medical, GENOSS, Elixir Medical, Andramed, Meril Life Science, and Sahajanand Laser Technology Limited. Companies in the Global Coronary Stents Market are strengthening their positions through continuous research and development to enhance stent safety, performance, and drug delivery capabilities. Firms are expanding their global footprint by entering emerging markets and forging partnerships with hospitals and healthcare providers. They focus on patient-centric and minimally invasive solutions, including bioresorbable and polymer-free stents, while integrating digital monitoring and smart stent technologies. Strategic marketing campaigns, clinician training programs, and collaborations with leading cardiac centers help companies improve adoption, build brand trust, and maintain a competitive edge in the global coronary stents industry.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Type trends
  • 2.2.4 Material trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of coronary artery disease
    • 3.2.1.2 Increasing demand for minimally invasive procedures
    • 3.2.1.3 Technological advancement in developing economies
    • 3.2.1.4 Increasing awareness and focus on preventive cardiac care
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Product failure and recall
    • 3.2.2.2 Stringent regulatory approvals
    • 3.2.2.3 Dearth of skilled healthcare professional in developing economies
  • 3.2.3 Market opportunities
    • 3.2.3.1 Development of bioresorbable and next-generation stents
    • 3.2.3.2 Integration of digital health & imaging technologies
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by primary research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Reimbursement scenario (Driven by primary research)
• 3.7 Future market trends
• 3.8 Pricing analysis, 2025 (Driven by primary research)
• 3.9 Porter's analysis
• 3.10 PESTEL analysis
• 3.11 Customer insights (Driven by primary research)
• 3.12 Start-up scenarios
• 3.13 Impact of AI and generative AI on the market
• 3.14 Investment landscape
• 3.15 Gap analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by primary research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Drug eluting stent
• 5.3 Bioresorbable vascular scaffold (BVS)
• 5.4 Bare metal stent

Chapter 6 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Balloon expendable stent
• 6.3 Self-expendable stent

Chapter 7 Market Estimates and Forecast, By Material, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Cobalt-chromium alloy
• 7.3 Stainless steel
• 7.4 Other materials

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Cardiac centers
• 8.3 Hospitals
• 8.4 Ambulatory surgical centers
• 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Abbott
• 10.2 Andramed
• 10.3 B. Braun
• 10.4 Biosensors International Group
• 10.5 Biotronik
• 10.6 Boston Scientific
• 10.7 Cook Medical
• 10.8 Elixir Medical
• 10.9 GENOSS
• 10.10 Medtronic
• 10.11 Meril Life Science
• 10.12 MicroPort Scientific
• 10.13 Sahajanand Laser Technology Limited
• 10.14 Stryker
• 10.15 Terumo